Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYBMC Psychiatry

The association of anxiety, depression, developmental disabilities, and congenital heart disease in US children and adolescents

  1. 1Department of Neonatology, Shanghai Children’s Medical Center GuiZhou Hospital, Shanghai Jiao Tong University School of Medicine

Abstract

Background Congenital heart disease (CHD) has been linked to the risk of mental health or some developmental disabilities, but there is limited research on the effect of CHD on children and adolescents’ mental health and developmental disabilities (varying severity) in the general children and adolescents’ population. Methods This nationally representative study included 52,846 children and adolescents aged 6–17 years who participated in the 2022–2023 National Survey of Children’s Health (NSCH) in the US from July 2022 to January 2024. Weighted adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by multivariable logistic regression models to investigate the association of CHD with anxiety, depression, and multiple developmental disabilities. Results Finally, 52,846 children and adolescents representing 38 million US youth aged 6–17 years (mean age 11.47 years, 95% CI: 11.41–11.52) were included. Children and adolescents with CHD was associated with a higher presence of of anxiety (OR, 1.80 [95% CI, 1.37–2.37]), depression (OR, 1.52 [95% CI, 1.02–2.27]), Down syndrome (OR, 25.59 [95% CI, 14.27–61.36]), behavior problems (OR, 2.39 [95% CI, 1.77–3.24]), developmental delay (OR, 3.16 [95% CI, 2.39–4.18]), intellectual disability (OR, 3.81 [95% CI, 2.29–6.33]), speech disorder (OR, 2.61 [95% CI, 1.99–3.43]), learning disability (OR, 2.39 [95% CI, 1.80–3.17]), autism spectrum disorder (ASD) (OR, 2.11 [95% CI, 1.35–3.28]) and attention deficit disorder/attention-deficit hyperactivity disorder (ADD/ADHD) (OR, 2.04 [95% CI, 1.52–2.72]), respectively. In stratified analyses, the ORs for depression, Tourette syndrome, behavior problems, developmental delay, speech disorder, learning disability, ASD, and ADD/ADHD were higher in moderate or severe status than in mild status. The results were similar in the sensitivity analyses. Conclusion In conclusion, this is the first nationally representative, population-based study to demonstrate that children and adolescents with CHD are associated with increased presence of anxiety, depression, and developmental disabilities in US children and adolescents. The presence of depression and developmental disabilities was higher in moderate or severe status than in mild status. Our findings suggested that early prevention, risk assessment, and support of mental health conditions and developmental disorders in high-risk children and adolescents, such as those with CHD. Clinical trial number Not applicable.

Related

  1. Differential roles of confidence and competence in the association between understanding and enjoyment of physical activity: developmental and demographic moderators in children and adolescents
    Tim Vernon, Maxine Gregory, Stuart Bonner +2
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  2. Exploring the association between bullying and depression symptoms among adolescents in Bangladesh: Findings from nationally representative survey
    Ruhul Amin, A S M Rafad Asgar
    PLOS Mental HealthPeer-reviewedCC BYFull textGeneral biologyPsychiatry & mental healthPLOSEurope PMCPMC
  3. Association between depression severity and self-medication practices among urban college-going adolescents in Bangladesh
    Md. Muktarul, Nourin Tamanna, Md. Nafis Abiaz +1
    Discover Public HealthPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  4. Association between timing of psychological intervention and reconstruction of worldview, life perspective, and values in adolescents with depression.
    Lin Chen
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCCrossref
  5. Associations Between Upright Cardiovascular-Autonomic Characteristics, Temporal Gait Measures, and Mediolateral Plantar Center-of-Force Measures in Adults with Developmental Disabilities: An Exploratory Cross-Sectional Study
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{yu2026association,
  title = {{The association of anxiety, depression, developmental disabilities, and congenital heart disease in US children and adolescents}},
  author = {Benli Yu and Bin Li and Xiaodan Deng and Ji Tang and Rong Chen and Tonglei Guo},
  journal = {BMC Psychiatry},
  year = {2026},
  month = jul,
  doi = {10.1186/s12888-026-08454-7},
  url = {https://doi.org/10.1186/s12888-026-08454-7},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The association of anxiety, depression, developmental disabilities, and congenital heart disease in US children and adolescents
AU  - Benli Yu
AU  - Bin Li
AU  - Xiaodan Deng
AU  - Ji Tang
AU  - Rong Chen
AU  - Tonglei Guo
PY  - 2026
DA  - 2026/07/01
JO  - BMC Psychiatry
DO  - 10.1186/s12888-026-08454-7
UR  - https://doi.org/10.1186/s12888-026-08454-7
AB  - Background Congenital heart disease (CHD) has been linked to the risk of mental health or some developmental disabilities, but there is limited research on the effect of CHD on children and adolescents’ mental health and developmental disabilities (varying severity) in the general children and adolescents’ population. Methods This nationally representative study included 52,846 children and adolescents aged 6–17 years who participated in the 2022–2023 National Survey of Children’s Health (NSCH) in the US from July 2022 to January 2024. Weighted adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by multivariable logistic regression models to investigate the association of CHD with anxiety, depression, and multiple developmental disabilities. Results Finally, 52,846 children and adolescents representing 38 million US youth aged 6–17 years (mean age 11.47 years, 95% CI: 11.41–11.52) were included. Children and adolescents with CHD was associated with a higher presence of of anxiety (OR, 1.80 [95% CI, 1.37–2.37]), depression (OR, 1.52 [95% CI, 1.02–2.27]), Down syndrome (OR, 25.59 [95% CI, 14.27–61.36]), behavior problems (OR, 2.39 [95% CI, 1.77–3.24]), developmental delay (OR, 3.16 [95% CI, 2.39–4.18]), intellectual disability (OR, 3.81 [95% CI, 2.29–6.33]), speech disorder (OR, 2.61 [95% CI, 1.99–3.43]), learning disability (OR, 2.39 [95% CI, 1.80–3.17]), autism spectrum disorder (ASD) (OR, 2.11 [95% CI, 1.35–3.28]) and attention deficit disorder/attention-deficit hyperactivity disorder (ADD/ADHD) (OR, 2.04 [95% CI, 1.52–2.72]), respectively. In stratified analyses, the ORs for depression, Tourette syndrome, behavior problems, developmental delay, speech disorder, learning disability, ASD, and ADD/ADHD were higher in moderate or severe status than in mild status. The results were similar in the sensitivity analyses. Conclusion In conclusion, this is the first nationally representative, population-based study to demonstrate that children and adolescents with CHD are associated with increased presence of anxiety, depression, and developmental disabilities in US children and adolescents. The presence of depression and developmental disabilities was higher in moderate or severe status than in mild status. Our findings suggested that early prevention, risk assessment, and support of mental health conditions and developmental disorders in high-risk children and adolescents, such as those with CHD. Clinical trial number Not applicable.
SN  - 1471-244X
ER  -